Clinical Trial Update: Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety of a herpes simplex vaccine candidate (gD2t) with adjuvant in HSV seropositive and seronegative individuals has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Simplex

Drugs mentioned

• Herpes Simplex Candidate Vaccine (gD2t) with Adjuvant (gD2t vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Prophylaxis for Herpes Simplex | Phase 3 | Status: COMPLETED